Baudax Bio
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Baudax Bio generated cash of -$27,793,000, which is more than the previous year. Cash used in financing activities reached the amount of $17,181,000 last year. Net change in cash is therefore -$10,632,000.
Cash Flow
| 2017 | -43.27M | -1.28M | 44.55M |
|---|---|---|---|
| 2018 | -59.75M | -3.45M | 63.20M |
| 2019 | -50.04M | -1.48M | 69.26M |
| 2020 | -44.05M | -639K | 57.29M |
| 2021 | -49.27M | -194K | 35.01M |
| 2022 | -27.79M | -20K | 17.18M |
BXRX Cash Flow Statement (2017 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 15.89M | 30.34M | 17.74M | 0 | 0 | 0 |
Operating activities | ||||||
Net income | -58.79M | -19.76M | -76.1M | -32.55M | -73.66M | -61.08M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 2.16M | 2.81M | 2.55M | 480K | 396K | 72K |
Stock-based compensation expense | 1.40M | 4.78M | 9.34M | 5.46M | 4.57M | 3.41M |
| Deferred income tax benefit | 1.40M | 4.78M | 9.34M | 5.46M | 4.57M | 3.41M |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | 207K | -491K | -51K | 0 | 0 | 0 |
Inventories | -280K | -2.02M | -2.97M | 0 | 0 | 0 |
Accounts payable | -1.3M | -1.48M | 4.61M | -8.99M | 493K | 2.61M |
Cash generated by operating activities | -27.79M | -49.27M | -44.05M | -50.04M | -59.75M | -43.27M |
Investing activities | ||||||
Purchases Of Investments | 0 | -19.64M | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -20K | -203K | -639K | -1.48M | -3.45M | -1.28M |
Acquisitions Net | 0 | -9K | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -20K | -194K | -639K | -1.48M | -3.45M | -1.28M |
Financing activities | ||||||
Common Stock Issued | 20.39M | 30.82M | 45.01M | 0 | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -3K | -97K | -475K | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | -10.04M | 0 | 0 | 0 |
Cash used in financing activities | 17.18M | 35.01M | 57.29M | 69.26M | 63.20M | 44.55M |
Net Change In Cash | -10.63M | -14.45M | 12.60M | 17.74M | 0 | 0 |
Cash at end of period | 5.25M | 15.89M | 30.34M | 17.74M | 0 | 0 |
| Data source | Data source | Data source | Data source |